<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">veterinary</journal-id><journal-title-group><journal-title xml:lang="en">Veterinary Science Today</journal-title><trans-title-group xml:lang="ru"><trans-title>Ветеринария сегодня</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2304-196X</issn><issn pub-type="epub">2658-6959</issn><publisher><publisher-name>"Veinard"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29326/2304-196X-2024-13-2-183-188</article-id><article-id custom-type="elpub" pub-id-type="custom">veterinary-818</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES | BIOTECHNOLOGY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ | БИОТЕХНОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>Studying immunotherapeutic properties of the conjugate based on BCG antigens with betulonic acid in guinea pigs infected with Mycobacterium scrofulaceum</article-title><trans-title-group xml:lang="ru"><trans-title>Изучение иммунотерапевтических свойств конъюгата антигенов БЦЖ с бетулоновой кислотой на морских свинках, инфицированных Mycobacterium scrofulaceum</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5537-219X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кошкин</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Koshkin</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кошкин Иван Николаевич, канд. вет. наук, старший научный сотрудник лаборатории эпизоотологии и мер борьбы с туберкулезом отдела ветеринарии</p><p>пр. Королева, 26, г. Омск, 644012 </p></bio><bio xml:lang="en"><p>Ivan N. Koshkin, Cand. Sci. (Veterinary Medicine), Senior Researcher, Laboratory of Epizootology and Tuberculosis Control, Department of Veterinary Medicine</p><p>26 Koroleva ave., Omsk 644012</p></bio><email xlink:type="simple">in.koshkin@omgau.org</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8351-2818</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Власенко</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Vlasenko</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Власенко Василий Сергеевич, д-р биол. наук, профессор, главный научный сотрудник лаборатории эпизоотологии и мер борьбы с туберкулезом отдела ветеринарии</p><p>пр. Королева, 26, г. Омск, 644012 </p></bio><bio xml:lang="en"><p>Vasily S. Vlasenko, Dr. Sci. (Biology), Professor, Chief Researcher, Laboratory of Epizootology and Tuberculosis Control, Department of Veterinary Medicine</p><p>26 Koroleva ave., Omsk 644012</p></bio><email xlink:type="simple">vvs-76@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0390-7121</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Денгис</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dengis</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Денгис Наталья Александровна, канд. биол. наук, ведущий научный сотрудник лаборатории эпизоотологии и мер борьбы с туберкулезом отдела ветеринарии</p><p>пр. Королева, 26, г. Омск, 644012 </p></bio><bio xml:lang="en"><p>Natalia A. Dengis, Cand. Sci. (Biology), Leading Researcher, Laboratory of Epizootology and Tuberculosis Control, Department of Veterinary Medicine</p><p>26 Koroleva ave., Omsk 644012 </p></bio><email xlink:type="simple">svir2007@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Омский аграрный научный центр» (ФГБНУ «Омский АНЦ»)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Omsk Agrarian Scientific Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>13</day><month>06</month><year>2024</year></pub-date><volume>13</volume><issue>2</issue><fpage>183</fpage><lpage>188</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Koshkin I.N., Vlasenko V.S., Dengis N.A., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Кошкин И.Н., Власенко В.С., Денгис Н.А.</copyright-holder><copyright-holder xml:lang="en">Koshkin I.N., Vlasenko V.S., Dengis N.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://veterinary.arriah.ru/jour/article/view/818">https://veterinary.arriah.ru/jour/article/view/818</self-uri><abstract><p>The paper reports on the research into the immunotherapeutic properties of a conjugate based on BCG antigens with betulonic acid after experimental infection of guinea pigs with Mycobacterium scrofulaceum culture, belonging to nontuberculosis mycobacteria type II according to the Runyon classification. Fifteen guinea pigs were used for the experimental purposes, divided into 3 groups. Mycobacterium scrofulaceum was subcutaneously injected into animals of Groups 1 and 2 (n = 10) at a dose of 5 mg. Fourteen days later, a conjugate based on BCG antigens with betulonic acid was subcutaneously injected into animals of Group 2 (n = 5) at a dose of 500 µg/mL of protein. Five intact animals were used as controls. During the experiment, neutrophil bactericidal activity was assessed, and histopathological examination of inguinal lymph nodes was done. The experiment showed that the inoculation of Mycobacterium scrofulaceum into guinea pigs activates cationic proteins and neutrophil myeloperoxidase, and on experiment day 42 (preceded by mycobacteria withdrawal from the body) their concentration reduced to the level of the control group. The vaccine administration induced a more active intracellular phagocyte metabolism during the entire observation period, which resulted in the elimination of nontuberculosis mycobacteria in animals as early as day 7 after treatment with the conjugate. The elimination was confirmed by the absence of mycobacterial antigen in blood smears tested in indirect immunofluorescence, as well as by histopathological changes in inguinal lymph nodes demonstrated as a reduction of germinal centers within lymphoid follicles.</p></abstract><trans-abstract xml:lang="ru"><p>В настоящей работе представлены результаты изучения иммунотерапевтических свойств препарата из антигенного комплекса БЦЖ, конъюгированного с бетулоновой кислотой, после экспериментального заражения морских свинок культурой Mycobacterium scrofulaceum, относящейся к нетуберкулезным микобактериям II типа по классификации Раньона. С этой целью проведен опыт на 15 морских свинках, из которых было сформировано 3 группы. Животным 1-й и 2-й групп (n = 10) подкожно инокулировали Mycobacterium scrofulaceum в дозе 5 мг, после чего особям 2-й группы (n = 5) через 14 сут подкожно вводили конъюгат антигенов БЦЖ с бетулоновой кислотой в дозе 500 мкг/мл белка. Пять интактных особей служили контролем. При проведении экспериментов оценивали функциональное состояние бактерицидных систем нейтрофилов, а также выполняли патогистологические исследования паховых лимфатических узлов. В результате было установлено, что сенсибилизация морских свинок Mycobacterium scrofulaceum активизирует деятельность катионных белков и миелопероксидазы нейтрофилов, и по мере выведения микобактерий из организма к 42-м сут от начала эксперимента их концентрация снижалась до уровня контрольной группы. Введение препарата индуцировало более выраженное усиление внутриклеточного метаболизма фагоцитов в течение всего срока наблюдения, способствуя элиминации нетуберкулезных микобактерий из организма животных уже на 7-е сут после обработки конъюгатом, что подтверждалось отсутствием микобактериального антигена в мазках крови при исследовании в реакции непрямой иммунофлуоресценции, а также патогистологическими изменениями в паховых лимфатических узлах, которые выражались уменьшением выраженных центров размножения в лимфатических фолликулах.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>нетуберкулезные микобактерии</kwd><kwd>морские свинки</kwd><kwd>бацилла Кальмета – Герена (БЦЖ)</kwd><kwd>бетулоновая кислота</kwd><kwd>нейтрофилы</kwd><kwd>паховые лимфатические узлы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>non-tuberculosis mycobacteria</kwd><kwd>guinea pigs</kwd><kwd>Bacillus Calmette-Guerin (BCG)</kwd><kwd>betulonic acid</kwd><kwd>neutrophils</kwd><kwd>inguinal lymph nodes</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Статья подготовлена при финансовой поддержке Министерства образования и науки РФ в рамках проведения научно-исследовательских работ по теме FNUN-2022-0035 «Разработка новых и усовершенствование существующих средств и методов диагностики и профилактики социальнозначимых инфекций с целью сохранения эпизоотического благополучия и получения качественной и безопасной продукции с учетом генетических баз данных и особенностей возбудителей, направлений и селекции животноводства, технологий кормления, экономических и географических условий». Авторы выражают благодарность профессору, доктору химических наук И. В. Кулакову за предоставление бетулоновой кислоты, синтезированной на кафедре органической и экологической химии Института химии ФГАОУ ВО «Тюменский государственный университет».</funding-statement><funding-statement xml:lang="en">The article was prepared with the financial support from the Ministry of Education and Science of the Russian Federation as part of the research project FNUN-2022-0035 “Developing new and improving existing tools and methods for diagnosis and prevention of socially significant infections in order to ensure freedom from epizooties and produce high-quality and safe products, taking into account genetic databases, characteristics of pathogens, trends in livestock breeding, feeding technologies, economic and geographical conditions”. The authors express their appreciation to Dr. Sci. (Chemisty), professor I. V. Kulakov for providing betulonic acid synthesized at the Department of Organic and Environmental Chemistry of the Institute of Chemistry of the University of Tyumen.</funding-statement></funding-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>Out of more than 190 currently known species of Mycobacterium genus a significant number belongs to non-tuberculous mycobacteria and over 60 species are pathogenic to animals and humans [<xref ref-type="bibr" rid="cit1">1</xref>][<xref ref-type="bibr" rid="cit2">2</xref>].</p><p>Non-tuberculous mycobacteria may be found ubiquitously in the environment and they pose a serious problem for in vivo and postmortem diagnosis of bovine tuberculosis as they cause false positive response to administration of tuberculin due to antigenic determinants in the allergen, which are common to non-tuberculous and pathogenic mycobacteria. In addition, visible and microscopic changes induced by non-tuberculous mycobacteria are in some cases difficult to distinguish from lesions caused by Mycobacterium tuberculosis and Mycobacterium bovis [<xref ref-type="bibr" rid="cit2">2</xref>][<xref ref-type="bibr" rid="cit3">3</xref>][<xref ref-type="bibr" rid="cit4">4</xref>][<xref ref-type="bibr" rid="cit5">5</xref>][<xref ref-type="bibr" rid="cit6">6</xref>].</p><p>Owing to a drop in bovine tuberculosis transmission and strong diagnostic measures taken to detect residual infection in the territories where disease control programs are in place, there has been an increase in mycobacterioses caused by non-tuberculous mycobacteria [<xref ref-type="bibr" rid="cit7">7</xref>][<xref ref-type="bibr" rid="cit8">8</xref>][<xref ref-type="bibr" rid="cit9">9</xref>][<xref ref-type="bibr" rid="cit10">10</xref>]. Despite the growing interest, little data has been published so far on non-tuberculous mycobacterial infections, and the available literature is mainly focused on the Mycobacterium avium complex and its subspecies [<xref ref-type="bibr" rid="cit11">11</xref>][<xref ref-type="bibr" rid="cit12">12</xref>][<xref ref-type="bibr" rid="cit13">13</xref>][<xref ref-type="bibr" rid="cit14">14</xref>][<xref ref-type="bibr" rid="cit15">15</xref>].</p><p>To solve the problem of non-specific reactions induced by non-tuberculous mycobacteria, specific immunoprophylactic or immunotherapeutic tools may be an extra option to complement lifetime differential tests (simultaneous, palpebral tests, etc.). Several recent studies suggest that cross-reactive response to non-tuberculous mycobacteria [<xref ref-type="bibr" rid="cit16">16</xref>][<xref ref-type="bibr" rid="cit17">17</xref>][<xref ref-type="bibr" rid="cit18">18</xref>][<xref ref-type="bibr" rid="cit19">19</xref>] is induced by BCG vaccination, as well as by immunization with areactogenic conjugates based on protective antigens, isolated from the BCG vaccine, with polyions [<xref ref-type="bibr" rid="cit20">20</xref>]. Conversely, some scientists claim that previous contacts with non-tuberculous mycobacteria may have an antagonistic effect, reducing vaccination effectiveness; however, this concern is only about live BCG vaccine and did not affect protective properties of inactivated subunit tuberculous vaccines [<xref ref-type="bibr" rid="cit21">21</xref>][<xref ref-type="bibr" rid="cit22">22</xref>][<xref ref-type="bibr" rid="cit23">23</xref>][<xref ref-type="bibr" rid="cit24">24</xref>].</p><p>From our perspective, conjugates based on BCG antigens with betulin and its derivatives (betulonic and betulinic acids) may look promising in this regard. In particular, molecular docking has shown that betulonic acid in most cases exhibits the highest inhibitory activity against protein targets that are structural parts of Mycobacterium tuberculosis and/or Mycobacterium bovis [<xref ref-type="bibr" rid="cit25">25</xref>].</p><p>In connection with the above, the purpose of this work is to study the immunotherapeutic efficacy of an experimental conjugate based on BCG antigens with betulonic acid.</p></sec><sec><title>MATERIALS AND METHODS</title><p>The experiment was conducted in Agouti guinea pigs in accordance with the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes as of 18 March 1986, and was approved by the local independent ethical committee of the organization for the care and use of laboratory animals. Experimental animals were grouped based on common characteristics (weight – 400–500 g, age – 4–5 months).</p><p>From 14- to 21-day scotochromogenic mycobacteria Mycobacterium scrofulaceum (Runyon II: Scotochromogens) was used to infect experimental animals. It was administered subcutaneously into the left groin, at a dose of 5 mg/mL. Mycobacterium cultures were administered to 10 animals, further divided into 2 groups: group 1 – infected with Mycobacterium scrofulaceum (n = 5); group 2 – infected with Mycobacterium scrofulaceum and on day 14 after the administration, they were treated with conjugate of BCG antigen with betulonic acid (n = 5). The other five intact guinea pigs were used as controls.</p><p>The experimental conjugate of BCG antigenic complexes with betulonic acid was designed in accordance with the author’s development. The preparation was administered subcutaneously to animals at a dose of 500 µg/mL of protein. Betulonic acid was synthesized at the Department of Organic and Environmental Chemistry of the Institute of Chemistry of the University of Tyumen and was kindly provided for research by Professor, Dr. Sci. (Chemistry) I. V. Kulakov.</p><p>Mycobacterial antigen in blood samples was detected using indirect immunofluorescence in accordance with the methodological recommendations of N. N. Novikova et al. [<xref ref-type="bibr" rid="cit26">26</xref>]. Myeloperoxidase activity and number of neutrophil cationic proteins were measured using benzidine test and bromophenol blue test with phagocyte distributed depending on the number of cytoplasmic granules (1st, 2nd and 3rd degrees), followed by calculation of average cytochemical coefficients (ACC) using standard methods.</p><p>Before the start of the experiment and on day 21 post infection, allergy tests were performed using intradermal administration of purified tuberculin for mammals. Blood was sampled for serological tests on day 21 and 42 after administration of scotochromogenic mycobacteria; and on days 14, 28 and 42 to assess functional status of neutrophils.</p><p>The laboratory animals were euthanized under ether anesthesia followed by total exsanguination on day 45 after the beginning of the experiment. For histological tests pieces of inguinal lymph nodes were taken (from regional lymph nodes, i.e. the closest ones to the site of mycobacteria inoculation, as well as from the lymph nodes on the opposite side). The sampled pieces were placed into cassettes and submerge in 10% neutral buffered formalin, and then the tissue was paraffin-embedded using MICROM EC 350 (Thermo Fisher Scientific Inc., USA). Rotary Microtome HM 340E (produced by Thermo Fisher Scientific Inc., USA) was used to cut sample sections, ranging between 5 and 7 µm. Histological tissue preparations were stained with hematoxylin and eosin, and then examined microscopically.</p><p>Standard methods of variational statistics were used, such as calculation of arithmetic means (M) and calculation of errors of arithmetic means (m), to process the obtained data. Student’s t-test was used to assess significance of differences (p) between the two mean values of Mx and My. The differences in the results were considered statistically significant at a significance level of p ≤ 0.05.</p></sec><sec><title>RESULTS AND DISCUSSION</title><p>Inoculation of Mycobacterium scrofulaceum to guinea pigs enhanced oxygen-independent mechanisms of neutrophils, as evidenced by a 1.60 and 1.74-fold increase in phagocytes with a large number of cytoplasmic granules (3rd degree) containing cationic proteins in group 1 and 2, respectively (p &lt; 0.01), as compared to the control group. Following these changes, average cytochemical coefficients also increased by a factor of 1.65 (Table 1).</p><table-wrap id="table-1"><caption><p>Table 1</p><p>Level of neutrophil cationic proteins in animals at different moments post inoculation of Mycobacterium scrofulaceum, M ± m</p><p>*p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001.</p></caption><table><tbody><tr><td>Cytochemical parameters</td><td>Group of animals</td></tr><tr><td>Control</td><td>Experimental group 1</td><td>Experimental group 2</td></tr><tr><td>Day 14 after inoculation of Mycobacterium</td></tr><tr><td>1st degree, %</td><td>5.00 ± 0.58</td><td>11.33 ± 3.33</td><td>10.00 ± 3.05</td></tr><tr><td>2nd degree, %</td><td>9.66 ± 1.67</td><td>16.66 ± 2.40</td><td>10.00 ± 1.15</td></tr><tr><td>3rd degree, %</td><td>33.00 ± 1.15</td><td>52.66 ± 5.78*</td><td>57.33 ± 4.37**</td></tr><tr><td>Average cytochemical coefficient, conditional units</td><td>1.23 ± 0.02</td><td>2.03 ± 0.11**</td><td>2.02 ± 0.12**</td></tr><tr><td>Day 28 after inoculation of Mycobacterium (day 14 after administration of the preparation)</td></tr><tr><td>1st degree, %</td><td>3.33 ± 0.67</td><td>8.33 ± 2.85</td><td>3.66 ± 0.88</td></tr><tr><td>2nd degree, %</td><td>14.00 ± 0.58</td><td>12.66 ± 2.40</td><td>9.66 ± 0.33**</td></tr><tr><td>3rd degree, %</td><td>29.33 ± 2.18</td><td>45.33 ± 1.33**</td><td>57.00 ± 4.04**</td></tr><tr><td>Average cytochemical coefficient, conditional units</td><td>1.19 ± 0.06</td><td>1.70 ± 0.05**</td><td>1.94 ± 0.11**</td></tr><tr><td>Day 42 after inoculation of Mycobacterium (day 28 after administration of the preparation)</td></tr><tr><td>1st degree, %</td><td>5.33 ± 2.33</td><td>5.00 ± 0.58</td><td>2.66 ± 1.76</td></tr><tr><td>2nd degree, %</td><td>11.00 ± 0.58</td><td>11.66 ± 0.88</td><td>7.00 ± 1.73</td></tr><tr><td>3rd degree, %</td><td>30.00 ± 4.58</td><td>33.33 ± 2.73</td><td>71.66 ± 2.03***</td></tr><tr><td>Average cytochemical coefficient, conditional units</td><td>1.17 ± 0.12</td><td>1.28 ± 0.08</td><td>2.31 ± 0.08**</td></tr></tbody></table></table-wrap><p>Delayed-type hypersensitivity response to a tuberculin test conducted on day 21 post infection of guinea pigs was observed only in 60% of animals who had not received experimental preparation (group 1). Nevertheless, mycobacterial antigen was detected in all animals of this group using indirect immunofluorescence. Mean induration size in the reactors was 4.33 ± 0.33 mm.</p><p>On day 28 following sensitization of guinea pigs with non-tuberculous mycobacteria type II (according to the Runyon classification) the same trend persisted, i.e. a significant increase in concentration of neutrophil cationic proteins in the experimental groups compared to the control group. The activity of neutrophil antimicrobial peptides was higher in the group that had been treated with the experimental preparation on day 14 after inoculation of scotochromogenic mycobacteria (group 2), and was at the same level that had been observed in the test two weeks before. In contrast, the metabolic processes in group 1 were less intensive compared to the previous testing.</p><p>After another 14 days, concentration of cationic proteins in guinea pigs of group 1 dropped to the control levels. Thus, the average cytochemical coefficient within the group was 1.28 ± 0.08 c. u., and 1.17 ± 0.12 c. u. in the control. In contrast, neutrophil oxygen-dependent metabolism in the animals immunized with the experimental conjugate was more active due to an increase in the number of highly active phagocytes by 2.39 times (p &lt; 0.001), thus, leading to a 1.97-fold increase in the average cytochemical coefficient (p &lt; 0.01).</p><p>The administration of Mycobacterium scrofulaceum to guinea pigs also stimulated neutrophil oxygen-dependent metabolism (Table 2). Thus, the level of the average cytochemical coefficient of myeloperoxidase increased with a high degree of confidence (p &lt; 0.01) by 1.79 and 1.82 times in both experimental groups, respectively, due to a 2-fold increase in the number of highly active phagocytes as compared to the control group.</p><table-wrap id="table-2"><caption><p>Table 2</p><p>Enzyme activity of neutrophil myeloperoxidase in animals at different moments post inoculation of Mycobacterium scrofulaceum, M ± m</p><p>*p &lt; 0.05; **p &lt; 0.01; ***p &lt; 0.001.</p></caption><table><tbody><tr><td>Cytochemical parameters</td><td>Group of animals</td></tr><tr><td>Control</td><td>Experimental group 1</td><td>Experimental group 2</td></tr><tr><td>Day 14 after inoculation of Mycobacterium</td></tr><tr><td>1st degree, %</td><td>9.33 ± 0.67</td><td>9.66 ± 0.88</td><td>10.33 ± 3.18</td></tr><tr><td>2nd degree, %</td><td>12.33 ± 1.85</td><td>18.66 ± 1.67</td><td>19.33 ± 2.33</td></tr><tr><td>3rd degree, %</td><td>21.33 ± 3.53</td><td>42.66 ± 1.33**</td><td>43.00 ± 3.21*</td></tr><tr><td>Average cytochemical coefficient, conditional units</td><td>0.98 ± 0.08</td><td>1.75 ± 0.06**</td><td>1.78 ± 0.02**</td></tr><tr><td>Day 28 after inoculation of Mycobacterium (day 14 after administration of the preparation)</td></tr><tr><td>1st degree, %</td><td>5.66 ± 0.67</td><td>15.00 ± 1.53</td><td>10.00 ± 0.58**</td></tr><tr><td>2nd degree, %</td><td>7.33 ± 2.60</td><td>14.66 ± 2.33</td><td>13.00 ± 2.08</td></tr><tr><td>3rd degree, %</td><td>23.33 ± 0.88</td><td>36.00 ± 5.68</td><td>44.66 ± 4.98*</td></tr><tr><td>Average cytochemical coefficient, conditional units</td><td>0.90 ± 0.06</td><td>1.52 ± 0.13*</td><td>1.70 ± 0.18*</td></tr><tr><td>Day 42 after inoculation of Mycobacterium (day 28 after administration of the preparation)</td></tr><tr><td>1st degree, %</td><td>7.66 ± 1.33</td><td>7.33 ± 0.33</td><td>5.66 ± 1.85</td></tr><tr><td>2nd degree, %</td><td>8.66 ± 2.33</td><td>13.66 ± 3.18</td><td>12.66 ± 1.45</td></tr><tr><td>3rd degree, %</td><td>26.00 ± 1.00</td><td>23.33 ± 2.03</td><td>59.33 ± 0.88***</td></tr><tr><td>Average cytochemical coefficient, conditional units</td><td>1.03 ± 0.03</td><td>1.05 ± 0.04</td><td>2.09 ± 0.01***</td></tr></tbody></table></table-wrap><p>Later, significantly increased myeloperoxidase enzyme activity was observed in guinea pigs of experimental group 2. Thus, the average cytochemical coefficients in the group after administration of the preparation were:</p><p>– on day 14, 1.70 ± 0.18 c. u. versus 0.90 ± 0.06 c. u. (p &lt; 0.05) in the control;</p><p>– on day 28, 2.09 ± 0.01 c. u. versus 1.03 ± 0.03 c. u. (p &lt; 0.001) in the control.</p><p>In contrast, as the time after inoculation with mycobacteria passed by, experimental group 1 demonstrated a decrease in the oxygen-dependent metabolism of neutrophils to the level of the control group (by day 42 from the beginning of the experiment).</p><p>Indirect immunofluorescence of blood samples tested on day 42 after inoculation of Mycobacterium scrofulaceum, demonstrated mycobacterial antigen only in 2 guinea pigs from experimental group 1.</p><p>Thus, administration of the immunobiological product enhances functional activity of aerobic and anaerobic neutrophil bactericidal systems resulting in accelerated elimination of non-tuberculous mycobacteria from the experimental animals.</p><p>Histopathological tests conducted on day 45 from the start of the experiment also demonstrate reduced antigen load on the guinea pigs treated with the experimental conjugate. Thus, an increase in the number of lymphatic follicles with a large proliferation center was observed in the regional inguinal lymph nodes of the animals from experimental group 1 (Fig. 1), where macrophage hyperplasia was recorded. Macrophage proliferation was also found in the cortex. The medullary cords housed mainly lymphocytes and an insignificant number of plasmocytes.</p><fig id="fig-1"><caption><p>Fig. 1. A lymphoid follicle with a large germinal center. Regional lymph node of a guinea pig (group 1). Staining with hematoxylin and eosin, magnification 50×</p></caption><graphic xlink:href="veterinary-13-2-g001.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/veterinary/2023/1/LTqPf8e5Wb4Tjo36DhHCjvhyh8euomZnfvOY5GPW.jpeg</uri></graphic></fig><p>In contrast, inguinal lymph node cortex in experimental group 2 was significantly thinner. The lymphoid follicles were also smaller; moreover, they lacked proliferation centers (Fig. 2), even if they had such centers, there were only dendritic reticulocytes in them.</p><fig id="fig-2"><caption><p>Fig. 2. Reduction of cortical substance volume and size of lymphatic follicles without germinal centres. Regional lymph node of a guinea pig (group 2). Staining with hematoxylin and eosin, magnification 50×</p></caption><graphic xlink:href="veterinary-13-2-g002.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/veterinary/2023/1/GSOfcjz1V4003izOHfocYRifo4pyK43jvx06snbs.jpeg</uri></graphic></fig><p>As for the inguinal lymph nodes adjacent to the site of Mycobacterium scrofulaceum inoculation, significantly fewer lymph follicles were observed there compared with the regional lymph nodes in the same group. Fewer proliferation centres were observed in them, and fewer macrophages were found in the proliferation centres and stroma. The animals treated with the preparation (group 2) had even fewer lymph follicles in the cortex of the lymph nodes located opposite to the regional ones.</p></sec><sec><title>CONCLUSION</title><p>The performed experiments demonstrate that sensitization of guinea pigs with Mycobacterium scrofulaceum induces hyper-reactivity of neutrophil intracellular bactericidal components lasting up to 28 days. Further on, there is a drop in their activity to the level recorded in animals of the control group. Administration of the experimental preparation accelerates withdrawal of mycobacteria from the guinea pigs (on day 7 post administration) owing to stimulation of phagocytes, which is confirmed by immunofluorescence and histological tests.</p><p>Contribution: Koshkin I. N. – conducting experiments, selection of scientific literature, preparation of digital images of microscopic tests, making article design; Vlasenko V. S. – concept of presentation, compilation of tables, statistical processing of results, interpretation of data and summarizing test results; Dengis N. A. – conducting experiments, assistance in the article design.</p><p>Вклад авторов: Кошкин И. Н. – проведение экспериментов, подбор научной литературы, подготовка цифровых снимков микроскопических исследований, оформление статьи; Власенко В. С. – концепция представления материалов, составление таблиц, статистическая обработка результатов, интерпретация данных и обобщение результатов исследования; Денгис Н. А. – проведение экспериментов, помощь в оформлении статьи.</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Parte A. C., Sardà Carbasse J., Meier-Kolthoff J. P., Reimer L. C., Göker M. List of prokaryotic names with standing in nomenclature (LPSN) moves to the DSMZ. International Journal of Systematic and Evolutionary Microbiology. 2020; 70 (11): 5607–5612. https://doi.org/10.1099/ijsem.0.004332</mixed-citation><mixed-citation xml:lang="en">Parte A. C., Sardà Carbasse J., Meier-Kolthoff J. P., Reimer L. C., Göker M. List of prokaryotic names with standing in nomenclature (LPSN) moves to the DSMZ. International Journal of Systematic and Evolutionary Microbiology. 2020; 70 (11): 5607–5612. https://doi.org/10.1099/ijsem.0.004332</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ghielmetti G., Friedel U., Scherrer S., Sarno E., Landolt P., Dietz O., et al. Non-tuberculous Mycobacteria isolated from lymph nodes and faecal samples of healthy slaughtered cattle and the abattoir environment. Transboundary and Emerging Diseases. 2018; 65 (3): 711–718. https://doi.org/10.1111/tbed.12793</mixed-citation><mixed-citation xml:lang="en">Ghielmetti G., Friedel U., Scherrer S., Sarno E., Landolt P., Dietz O., et al. Non-tuberculous Mycobacteria isolated from lymph nodes and faecal samples of healthy slaughtered cattle and the abattoir environment. Transboundary and Emerging Diseases. 2018; 65 (3): 711–718. https://doi.org/10.1111/tbed.12793</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Найманов А. Х., Гулюкин М. И., Толстенко Н. Г., Вангели Е. П., Калмыков В. М. Организация оздоровительных мер борьбы с туберкулезом животных в России. Ветеринария. 2019; (4): 3–7. https://doi.org/10.30896/0042-4846.2019.22.4.03-07</mixed-citation><mixed-citation xml:lang="en">Naimanov A. H., Gulukin M. I., Tolstenko N. G., Vangeli E. P., Kalmykov V. M. Organization of the fight against animal tuberculosis in Russia. Veterinariya. 2019; (4): 3–7. https://doi.org/10.30896/0042-4846.2019.22.4.03-07 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Баратов М. О., Сакидибиров О. П., Абдурагимова Р. М., Джабарова Г. А. Иммунные и протективные свойства нетуберкулезных кислотоустойчивых микобактерий. Проблемы развития АПК региона. 2022; (1): 73–79. https://doi.org/10.52671/20790996_2022_1_73</mixed-citation><mixed-citation xml:lang="en">Baratov M. O., Sakidibirov O. P., Abduragimova R. M., Dzhabarova G. A. Immune and protective properties of non-tuberculosis acid-resistant mycobacteria. Problems of Development of the Agro-Industrial Complex of the Region. 2022; (1): 73–79. https://doi.org/10.52671/20790996_2022_1_73 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Nuru A., Zewude A., Mohammed T., Wondale B., Teshome L., Getahun M., et al. Nontuberculosis mycobacteria are the major causes of tuberculosis like lesions in cattle slaughtered at Bahir Dar Abattoir, northwestern Ethiopia. BMC Veterinary Research. 2017; 13 (1):237. https://doi.org/10.1186/s12917-017-1168-3</mixed-citation><mixed-citation xml:lang="en">Nuru A., Zewude A., Mohammed T., Wondale B., Teshome L., Getahun M., et al. Nontuberculosis mycobacteria are the major causes of tuberculosis like lesions in cattle slaughtered at Bahir Dar Abattoir, northwestern Ethiopia. BMC Veterinary Research. 2017; 13 (1):237. https://doi.org/10.1186/s12917-017-1168-3</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hernández-Jarguín A. M., Martínez-Burnes J., Molina-Salinas G. M., de la Cruz-Hernández N. I., Palomares-Rangel J. L., López Mayagoitia A., Barrios-García H. B. Isolation and histopathological changes associated with non-tuberculous mycobacteria in lymph nodes condemned at a bovine slaughterhouse. Veterinary Sciences. 2020; 7 (4):172. https://doi.org/10.3390/vetsci7040172</mixed-citation><mixed-citation xml:lang="en">Hernández-Jarguín A. M., Martínez-Burnes J., Molina-Salinas G. M., de la Cruz-Hernández N. I., Palomares-Rangel J. L., López Mayagoitia A., Barrios-García H. B. Isolation and histopathological changes associated with non-tuberculous mycobacteria in lymph nodes condemned at a bovine slaughterhouse. Veterinary Sciences. 2020; 7 (4):172. https://doi.org/10.3390/vetsci7040172</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gomez-Buendia A., Alvarez J., Bezos J., Mourelo J., Amado J., Saez J. L., et al. Non-tuberculous mycobacteria: occurrence in skin test cattle reactors from official tuberculosis-free herds. Frontiers in Veterinary Science. 2024; 11:1361788. https://doi.org/10.3389/fvets.2024.1361788</mixed-citation><mixed-citation xml:lang="en">Gomez-Buendia A., Alvarez J., Bezos J., Mourelo J., Amado J., Saez J. L., et al. Non-tuberculous mycobacteria: occurrence in skin test cattle reactors from official tuberculosis-free herds. Frontiers in Veterinary Science. 2024; 11:1361788. https://doi.org/10.3389/fvets.2024.1361788</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Камалиева Ю. Р., Мингалеев Д. Н., Равилов Р. Х. Идентификация микобактерий нетуберкулезного типа, изолированных от крупного рогатого скота в Республике Татарстан. Аграрная наука. 2021; 354 (11–12): 32–35. https://doi.org/10.32634/0869-8155-2021-354-11-12-32-35</mixed-citation><mixed-citation xml:lang="en">Kamalieva Yu. R., Mingaleev D. N., Ravilov R. Kh. Identification of non-tuberculosis mycobacteria isolated from cattle in the Republic of Tatarstan. Agrarian Science. 2021; 354 (11–12): 32–35. https://doi.org/10.32634/0869-8155-2021-354-11-12-32-35 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Баратов М. О., Гусейнова П. С. Актуализированная эпизоотическая ситуация по туберкулезу крупного рогатого скота в Республике Дагестан. Ветеринария сегодня. 2022; 11 (3): 222–228. https://doi.org/10.29326/2304-196X-2022-11-3-222-228</mixed-citation><mixed-citation xml:lang="en">Baratov M. O., Huseynova P. S. Actual bovine tuberculosis situation in the Republic of Dagestan. Veterinary Science Today. 2022; 11 (3): 222–228. https://doi.org/10.29326/2304-196X-2022-11-3-222-228</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Biet F., Boschiroli M. L. Non-tuberculous mycobacterial infections of veterinary relevance. Research in Veterinary Science. 2014; 97 (Suppl.): S69–S77. https://doi.org/10.1016/j.rvsc.2014.08.007</mixed-citation><mixed-citation xml:lang="en">Biet F., Boschiroli M. L. Non-tuberculous mycobacterial infections of veterinary relevance. Research in Veterinary Science. 2014; 97 (Suppl.): S69–S77. https://doi.org/10.1016/j.rvsc.2014.08.007</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lara G. H. B., Ribeiro M. G., Leite C. Q. F., Paes A. C., Guazzelli A., da Silva A.V., et al. Occurrence of Mycobacteriumspp. and other pathogens in lymph nodes of slaughtered swine and wild boars (Sus scrofa). Research in Veterinary Science. 2011; 90 (2): 185–188. https://doi.org/10.1016/j.rvsc.2010.06.009</mixed-citation><mixed-citation xml:lang="en">Lara G. H. B., Ribeiro M. G., Leite C. Q. F., Paes A. C., Guazzelli A., da Silva A.V., et al. Occurrence of Mycobacteriumspp. and other pathogens in lymph nodes of slaughtered swine and wild boars (Sus scrofa). Research in Veterinary Science. 2011; 90 (2): 185–188. https://doi.org/10.1016/j.rvsc.2010.06.009</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Klanicova-Zalewska B., Slana I. Presence and persistence of Mycobacterium avium and other nontuberculous mycobacteria in animal tissuesand derived foods: a review. Meat Science. 2014; 98 (4): 835–841. https://doi.org/10.1016/j.meatsci.2014.08.001</mixed-citation><mixed-citation xml:lang="en">Klanicova-Zalewska B., Slana I. Presence and persistence of Mycobacterium avium and other nontuberculous mycobacteria in animal tissues and derived foods: a review. Meat Science. 2014; 98 (4): 835–841. https://doi.org/10.1016/j.meatsci.2014.08.001</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Varela-Castro L., Barral M., Arnal M. C., Fernández de Luco D., Gortázar C., Garrido J. M., Sevilla I. A. Beyond tuberculosis: Diversity and implications of non-tuberculous mycobacteria at the wildlife-livestock interface. Transboundary and Emerging Diseases. 2022; 69 (5): e2978–e2993. https://doi.org/10.1111/tbed.14649</mixed-citation><mixed-citation xml:lang="en">Varela-Castro L., Barral M., Arnal M. C., Fernández de Luco D., Gortázar C., Garrido J. M., Sevilla I. A. Beyond tuberculosis: Diversity and implications of non-tuberculous mycobacteria at the wildlife-livestock interface. Transboundary and Emerging Diseases. 2022; 69 (5): e2978–e2993. https://doi.org/10.1111/tbed.14649</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Muwonge A., Oloya J., Kankya C., Nielsen S., Godfroid J., Skjerve E., et al. Molecular characterization of Mycobacterium avium subspecies hominissuis isolated from humans, cattle and pigs in the Uganda cattle corridor using VNTR analysis. Infection, Genetics and Evolution. 2014; 21: 184–191. https://doi.org/10.1016/j.meegid.2013.11.012</mixed-citation><mixed-citation xml:lang="en">Muwonge A., Oloya J., Kankya C., Nielsen S., Godfroid J., Skjerve E., et al. Molecular characterization of Mycobacterium avium subspecies hominissuis isolated from humans, cattle and pigs in the Uganda cattle corridor using VNTR analysis. Infection, Genetics and Evolution. 2014; 21: 184–191. https://doi.org/10.1016/j.meegid.2013.11.012</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Leão C., Canto A., Machado D., Sanches I. S., Couto I., Viveiros M., et al. Relatedness of Mycobacterium avium subspecies hominissuis clinical isolates of human and porcine origins assessed by MLVA. Veterinary Microbiology. 2014; 173 (1–2): 92–100. https://doi.org/10.1016/j.vetmic.2014.06.027</mixed-citation><mixed-citation xml:lang="en">Leão C., Canto A., Machado D., Sanches I. S., Couto I., Viveiros M., et al. Relatedness of Mycobacterium avium subspecies hominissuis clinical isolates of human and porcine origins assessed by MLVA. Veterinary Microbiology. 2014; 173 (1–2): 92–100. https://doi.org/10.1016/j.vetmic.2014.06.027</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kontturi A., Soini H., Ollgren J., Salo E. Increase in childhood nontuberculous mycobacterial infections after bacille Calmette-Guérin coverage drop: A nationwide, population-based retrospective study, Finland, 1995–2016. Clinical Infectious Diseases. 2018; 67 (8): 1256–1261. https://doi.org/10.1093/cid/ciy241</mixed-citation><mixed-citation xml:lang="en">Kontturi A., Soini H., Ollgren J., Salo E. Increase in childhood nontuberculous mycobacterial infections after bacille Calmette-Guérin coverage drop: A nationwide, population-based retrospective study, Finland, 1995–2016. Clinical Infectious Diseases. 2018; 67 (8): 1256–1261. https://doi.org/10.1093/cid/ciy241</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmermann P., Finn A., Curtis N. Does BCG vaccination protect against nontuberculous mycobacterial infection? A systematic review and meta-analysis. The Journal of Infectious Diseases. 2018; 218 (5): 679–687. https://doi.org/10.1093/infdis/jiy207</mixed-citation><mixed-citation xml:lang="en">Zimmermann P., Finn A., Curtis N. Does BCG vaccination protect against nontuberculous mycobacterial infection? A systematic review and meta-analysis. The Journal of Infectious Diseases. 2018; 218 (5): 679–687. https://doi.org/10.1093/infdis/jiy207</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Abate G., Hamzabegovic F., Eickhoff C. S., Hoft D. F. BCG vaccination induces M. avium and M. abscessus cross-protective immunity. Frontiers in Immunology. 2019; 10:234. https://doi.org/10.3389/fimmu.2019.00234</mixed-citation><mixed-citation xml:lang="en">Abate G., Hamzabegovic F., Eickhoff C. S., Hoft D. F. BCG vaccination induces M. avium and M. abscessus cross-protective immunity. Frontiers in Immunology. 2019; 10:234. https://doi.org/10.3389/fimmu.2019.00234</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Fritschi N., Curtis N., Ritz N. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects. Paediatric Respiratory Reviews. 2020; 36: 57–64. https://doi.org/10.1016/j.prrv.2020.08.004</mixed-citation><mixed-citation xml:lang="en">Fritschi N., Curtis N., Ritz N. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects. Paediatric Respiratory Reviews. 2020; 36: 57–64. https://doi.org/10.1016/j.prrv.2020.08.004</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Власенко В. С., Кособоков Е. А., Денгис Н. А., Новикова Н. Н. Изучение иммунотерапевтических свойств иммуномодулятора КИМ-М2 на морских свинках, инфицированных нетуберкулезными микобактериями. Вестник КрасГАУ. 2022; (5): 91–97. https://doi.org/10.36718/1819-4036-2022-5-91-97</mixed-citation><mixed-citation xml:lang="en">Vlasenko V. S., Kosobokov E. A., Dengis N. A., Novikova N. N. Studying immunotherapeutic properties of the immunomodulator KIM-M2 in guinea pigs infected with nontuberculous mycobacteria. Bulletin of KrasSAU. 2022; (5): 91–97. https://doi.org/10.36718/1819-4036-2022-5-91-97 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Orme I. M., Collins F. M. Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria. Infection and Immunity. 1984; 44 (1): 28–32. https://doi.org/10.1128/iai.44.1.28-32.1984</mixed-citation><mixed-citation xml:lang="en">Orme I. M., Collins F. M. Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria. Infection and Immunity. 1984; 44 (1): 28–32. https://doi.org/10.1128/iai.44.1.28-32.1984</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Buddle B. M., Wards B. J., Aldwell F. E., Collins D. M., de Lisle G. W. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine. 2002; 20 (7–8): 1126–1133. https://doi.org/10.1016/S0264-410X(01)00436-4</mixed-citation><mixed-citation xml:lang="en">Buddle B. M., Wards B. J., Aldwell F. E., Collins D. M., de Lisle G. W. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine. 2002; 20 (7–8): 1126–1133. https://doi.org/10.1016/S0264-410X(01)00436-4</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Palmer M. V., Thacker T. C. Use of the human vaccine, Mycobacterium bovis Bacillus Calmette Guérin in deer. Frontiers in Veterinary Science. 2018; 5:244. https://doi.org/10.3389/fvets.2018.00244</mixed-citation><mixed-citation xml:lang="en">Palmer M. V., Thacker T. C. Use of the human vaccine, Mycobacterium bovis Bacillus Calmette Guérin in deer. Frontiers in Veterinary Science. 2018; 5:244. https://doi.org/10.3389/fvets.2018.00244</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Shah J. A., Lindestam Arlehamn C. S., Horne D. J., Sette A., Hawn T. R. Nontuberculous mycobacteria and heterologous immunity to tuberculosis. The Journal of Infectious Diseases. 2019; 220 (7): 1091–1098. https://doi.org/10.1093/infdis/jiz285</mixed-citation><mixed-citation xml:lang="en">Shah J. A., Lindestam Arlehamn C. S., Horne D. J., Sette A., Hawn T. R. Nontuberculous mycobacteria and heterologous immunity to tuberculosis. The Journal of Infectious Diseases. 2019; 220 (7): 1091–1098. https://doi.org/10.1093/infdis/jiz285</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Koshkin I. N., Vlasenko V. S., Pleshakova V. I., Alkhimova L. E., Elyshev A. V., Kulakov I. V. Morphology of lymphoid tissue in the lungs of guinea pigs infected with Mycobacterium bovis against the background of vaccine immunity and the action of betulin and its derivatives. Vaccines. 2022; 10 (12):2084. https://doi.org/10.3390/vaccines10122084</mixed-citation><mixed-citation xml:lang="en">Koshkin I. N., Vlasenko V. S., Pleshakova V. I., Alkhimova L. E., Elyshev A. V., Kulakov I. V. Morphology of lymphoid tissue in the lungs of guinea pigs infected with Mycobacterium bovis against the background of vaccine immunity and the action of betulin and its derivatives. Vaccines. 2022; 10 (12):2084. https://doi.org/10.3390/vaccines10122084</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Новикова Н. Н., Байсеитов С. Т., Власенко В. С., Красиков А. П. Применение реакции непрямой иммунофлюоресценции для диагностики лейкоза крупного рогатого скота: методические рекомендации. Алматы: NOVA Press; 2020. 17 с</mixed-citation><mixed-citation xml:lang="en">Novikova N. N., Baiseitov S. T., Vlasenko V. S., Krasikov A. P. Using indirect immunofluorescence to diagnose bovine leukosis: guidelines. Almaty: NOVA Press; 2020. 17 p. (in Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
